Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 635

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years

Mack, Michael J., Leon, Martin B., Thourani, Vinod H., Pibarot, Philippe, Hahn, Rebecca T., Genereux, Philippe, Kodali, Susheel K., Kapadia, Samir R., Cohen, David J., Pocock, Stuart J., Lu, Michael, White, Roseann, Szerlip, Molly, Ternacle, Julien, Malaisrie, S. Chris, Herrmann, Howard C., Szeto, Wilson Y., Russo, Mark J., Babaliaros, Vasilis, Smith, Craig R., Blanke, Philipp, Webb, John G., Makkar, Raj·2023·New England Journal of Medicine

Abstract

BACKGROUND: A previous analysis in this trial showed that among patients with severe, symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end point of death, stroke, or rehospitalization at 1 year was significantly lower with transcatheter aortic-valve replacement (TAVR) than with surgical aortic-valve replacement. Longer-term outcomes are unknown. METHODS: We randomly assigned patients with severe, symptomatic aortic stenosis and low surgical risk to undergo either TAVR or surgery. The first primary end point was a composite of death, stroke, or rehospitalization related to the valve, the procedure, or heart failure. The second primary end point was a hierarchical composite that included death, disabling stroke, nondisabling stroke, and the number of rehospitalization days, analyzed with the use of a win ratio analysis. Clinical, echocardiographic, and health-status outcomes were assessed through 5 years. RESULTS: A total of 1000 patients underwent randomization: 503 patients were assigned to undergo TAVR, and 497 to undergo surgery. A component of the first primary end point occurred in 111 of 496 patients in the TAVR group and in 117 of 454 patients in the surgery group (Kaplan-Meier estimates, 22.8% in the TAVR group and 27.2% in the surgery group; difference, -4.3 percentage points; 95% confidence interval [CI], -9.9 to 1.3; P = 0.07). The win ratio for the second primary end point was 1.17 (95% CI, 0.90 to 1.51; P = 0.25). The Kaplan-Meier estimates for the components of the first primary end point were as follows: death, 10.0% in the TAVR group and 8.2% in the surgery group; stroke, 5.8% and 6.4%, respectively; and rehospitalization, 13.7% and 17.4%. The hemodynamic performance of the valve, assessed according to the mean (±SD) valve gradient, was 12.8±6.5 mm Hg in the TAVR group and 11.7±5.6 mm Hg in the surgery group. Bioprosthetic-valve failure occurred in 3.3% of the patients in the TAVR group and in 3.8% of those in the surgery group. CONCLUSIONS: Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes. (Funded by Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov number, NCT02675114.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2307447

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 635

Metadata

Authors
Mack, M. J., Leon, M. B., Thourani, V. H., Pibarot, P., Hahn, R. T., Genereux, P., Kodali, S. K., Kapadia, S. R., Cohen, D. J., Pocock, S. J., Lu, M., White, R., Szerlip, M., Ternacle, J., Malaisrie, S. C., Herrmann, H. C., Szeto, W. Y., Russo, M. J., Babaliaros, V., Smith, C. R., Blanke, P., Webb, J. G., & Makkar, R.
Venue
New England Journal of Medicine
Published
2023-11-23
Volume
389
Issue
21
Pages
1949-1960
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4387893182
Cited by
635
References
28
FWCI
111.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. https://app.cochat.ai/papers/10.1056/nejmoa2307447
The paper
Mack, M. J., Leon, M. B., Thourani, V. H., Pibarot, P., Hahn, R. T., Genereux, P., Kodali, S. K., Kapadia, S. R., Cohen, D. J., Pocock, S. J., Lu, M., White, R., Szerlip, M., Ternacle, J., Malaisrie, S. C., Herrmann, H. C., Szeto, W. Y., Russo, M. J., Babaliaros, V., . . . Makkar, R. (2023). Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2307447

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.